Discovery of a potent and selective fragment-like inhibitor of methyllysine reader protein spindlin 1 (SPIN1)

By screening an epigenetic compound library, we identified that UNC0638, a highly potent inhibitor of the histone methyltransferases G9a and GLP, was a weak inhibitor of SPIN1 (spindlin 1), a methyllysine reader protein. Our optimization of this weak hit resulted in the discovery of a potent, select...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Xiong, Y, Greschik, H, Johansson, C, Seifert, L, Bacher, J, Park, K, Babault, N, Martini, M, Fagan, V, Li, F, Chau, I, Christott, T, Dilworth, D, Barsyte-Lovejoy, D, Vedadi, M, Arrowsmith, C, Brennan, P, Fedorov, O, Jung, M, Farnie, G, Liu, J, Oppermann, U, Schüle, R, Jin, J
Formatua: Journal article
Hizkuntza:English
Argitaratua: American Chemical Society 2019
_version_ 1826268309621833728
author Xiong, Y
Greschik, H
Johansson, C
Seifert, L
Bacher, J
Park, K
Babault, N
Martini, M
Fagan, V
Li, F
Chau, I
Christott, T
Dilworth, D
Barsyte-Lovejoy, D
Vedadi, M
Arrowsmith, C
Brennan, P
Fedorov, O
Jung, M
Farnie, G
Liu, J
Oppermann, U
Schüle, R
Jin, J
author_facet Xiong, Y
Greschik, H
Johansson, C
Seifert, L
Bacher, J
Park, K
Babault, N
Martini, M
Fagan, V
Li, F
Chau, I
Christott, T
Dilworth, D
Barsyte-Lovejoy, D
Vedadi, M
Arrowsmith, C
Brennan, P
Fedorov, O
Jung, M
Farnie, G
Liu, J
Oppermann, U
Schüle, R
Jin, J
author_sort Xiong, Y
collection OXFORD
description By screening an epigenetic compound library, we identified that UNC0638, a highly potent inhibitor of the histone methyltransferases G9a and GLP, was a weak inhibitor of SPIN1 (spindlin 1), a methyllysine reader protein. Our optimization of this weak hit resulted in the discovery of a potent, selective, and cell-active SPIN1 inhibitor, compound 3 (MS31). Compound 3 potently inhibited binding of trimethyllysine-containing peptides to SPIN1, displayed high binding affinity, was highly selective for SPIN1 over other epigenetic readers and writers, directly engaged SPIN1 in cells, and was not toxic to nontumorigenic cells. The crystal structure of the SPIN1–compound 3 complex indicated that it selectively binds tudor domain II of SPIN1. We also designed a structurally similar but inactive compound 4 (MS31N) as a negative control. Our results have demonstrated for the first time that potent, selective, and cell-active fragment-like inhibitors can be generated by targeting a single tudor domain.
first_indexed 2024-03-06T21:07:42Z
format Journal article
id oxford-uuid:3d071394-ac78-46e4-b5a4-2c8a8f713183
institution University of Oxford
language English
last_indexed 2024-03-06T21:07:42Z
publishDate 2019
publisher American Chemical Society
record_format dspace
spelling oxford-uuid:3d071394-ac78-46e4-b5a4-2c8a8f7131832022-03-26T14:17:13ZDiscovery of a potent and selective fragment-like inhibitor of methyllysine reader protein spindlin 1 (SPIN1)Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3d071394-ac78-46e4-b5a4-2c8a8f713183EnglishSymplectic Elements at OxfordAmerican Chemical Society2019Xiong, YGreschik, HJohansson, CSeifert, LBacher, JPark, KBabault, NMartini, MFagan, VLi, FChau, IChristott, TDilworth, DBarsyte-Lovejoy, DVedadi, MArrowsmith, CBrennan, PFedorov, OJung, MFarnie, GLiu, JOppermann, USchüle, RJin, JBy screening an epigenetic compound library, we identified that UNC0638, a highly potent inhibitor of the histone methyltransferases G9a and GLP, was a weak inhibitor of SPIN1 (spindlin 1), a methyllysine reader protein. Our optimization of this weak hit resulted in the discovery of a potent, selective, and cell-active SPIN1 inhibitor, compound 3 (MS31). Compound 3 potently inhibited binding of trimethyllysine-containing peptides to SPIN1, displayed high binding affinity, was highly selective for SPIN1 over other epigenetic readers and writers, directly engaged SPIN1 in cells, and was not toxic to nontumorigenic cells. The crystal structure of the SPIN1–compound 3 complex indicated that it selectively binds tudor domain II of SPIN1. We also designed a structurally similar but inactive compound 4 (MS31N) as a negative control. Our results have demonstrated for the first time that potent, selective, and cell-active fragment-like inhibitors can be generated by targeting a single tudor domain.
spellingShingle Xiong, Y
Greschik, H
Johansson, C
Seifert, L
Bacher, J
Park, K
Babault, N
Martini, M
Fagan, V
Li, F
Chau, I
Christott, T
Dilworth, D
Barsyte-Lovejoy, D
Vedadi, M
Arrowsmith, C
Brennan, P
Fedorov, O
Jung, M
Farnie, G
Liu, J
Oppermann, U
Schüle, R
Jin, J
Discovery of a potent and selective fragment-like inhibitor of methyllysine reader protein spindlin 1 (SPIN1)
title Discovery of a potent and selective fragment-like inhibitor of methyllysine reader protein spindlin 1 (SPIN1)
title_full Discovery of a potent and selective fragment-like inhibitor of methyllysine reader protein spindlin 1 (SPIN1)
title_fullStr Discovery of a potent and selective fragment-like inhibitor of methyllysine reader protein spindlin 1 (SPIN1)
title_full_unstemmed Discovery of a potent and selective fragment-like inhibitor of methyllysine reader protein spindlin 1 (SPIN1)
title_short Discovery of a potent and selective fragment-like inhibitor of methyllysine reader protein spindlin 1 (SPIN1)
title_sort discovery of a potent and selective fragment like inhibitor of methyllysine reader protein spindlin 1 spin1
work_keys_str_mv AT xiongy discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT greschikh discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT johanssonc discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT seifertl discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT bacherj discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT parkk discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT babaultn discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT martinim discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT faganv discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT lif discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT chaui discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT christottt discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT dilworthd discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT barsytelovejoyd discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT vedadim discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT arrowsmithc discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT brennanp discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT fedorovo discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT jungm discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT farnieg discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT liuj discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT oppermannu discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT schuler discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1
AT jinj discoveryofapotentandselectivefragmentlikeinhibitorofmethyllysinereaderproteinspindlin1spin1